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ThiolsAbstract The number of diabetes mellitus (DM) patients is one of the major concerns worldwide.
As one of the main mechanisms of DM pathology is the involvement of oxidative stress, here we
investigate the antioxidant capacities of frankincense (FRN) to treat or reduce the DM complica-
tions in the brain cortices of DM rats. Animals were segregated into four groups, the control group,
FRN group given a dose of 500 mg of FRN/kg for 5 weeks, DM group given a single dose of 150/kg
i.p of alloxan to induce diabetes and DM+ FRN group given a single dose of 150/kg i.p to induce
DM then followed by FRN 500 mg/kg for 5 weeks. The animals were sacrificed; their cerebral cor-
tices were removed and used for biochemical and histopathological analyses.
Alloxan treatment in the DM group showed significant reductions in catalase (CAT) activity and
other non-enzymatic antioxidants i.e. thiol groups, concomitant with decreases in the levels of pro-
tein and albumin and increasing the level of uric acid. However, FRN administration to DM ani-
mals in DM+ FRN group showed significant recovery of antioxidants, the thiol contents (total
thiols, protein thiols and glutathione) of DM+ FRN group have been increased as compared with
DM animals (p< 0.05). A recovery of CAT activity (p< 0.05) to almost the levels of control rats
with the recovery in protein and albumin levels (p< 0.05) have been observed when FRN was
administered. The uric acid level increased in DM group, came back to the levels of control after
administration of FRN (p< 0.05). We also observed that FRN reduces the histopathological dam-
age caused by alloxan in DM+ FRN group. It is concluded that FRN shows a beneficial effects
that can reduce the oxidative damage caused by alloxan induced DM in the cortex of rats.
 2016 University of Bahrain. Publishing services by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).iols
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The increasing patient’s number of diabetes mellitus (DM),
expected to be 552 million by 2030, had lead the researchers
to evaluate the capacity of natural products to either reduce
or cure the complications of the disease (Whiting et al.,
2011). DM has been shown to be a risk factor in the brains,
causing cognitive impairments and dementia because the brain
is the main glucose consumers with a 60% use of the total
body’s glucose (Biessels et al., 2006; Exalto et al., 2012;
Gorelick et al., 2011; Wasserman, 2009). One of the main fea-
tures of DM is high glucose level, which advances to glycation
end-products and will subsequently produce reactive oxygen
species (ROS) which will result in cell damage and apoptosis
(Brownlee, 2005). Two types of DM are known with at least
80% of cases having type II DM, also called non-insulin
dependent DM, which can be induced in the animal models
by injection of chemical compounds that have similarities with
glucose in the body, such as alloxan yielding the main charac-
teristics of DM include body weight loss, hyperglycemia, poly-
uria and dysregulation of insulin levels (King, 2012). Because
of the lower side effects of the natural products, many medic-
inal plants have been used to cure different diseases. Frankin-
cense (FRN) is one of those plants which is an aromatic resin
obtained from species of the Burseraceae family. Boswellia
sacra has been reported to possess a variety of pharmacologi-
cal effects including anti-hyperglycemia effect, antioxidant
effects, and anti-inflammatory effects (Akihisa et al., 2006;
Banno et al., 2006; Gupta et al., 1998; Mothana, 2011;
Mothana et al., 2007; Masoud et al., 2014). FRN extract has
also been reported to possess antidiabetic action in
streptozotocin- and alloxan-induced DM (Azemi et al., 2012;
Kavitha et al., 2007; Masoud et al., 2014). The present study
has been designed to study the possible antioxidant effects of
FRN on rat’s brain cortices following DM development.
2. Materials and methods
2.1. Preparation of the FRN extract
The freshly obtained plant from Hadramout Governorate,
Yemen was grinded, suspended in ethanol (96%), shacked
for 4 h and the extract was prepared as described previously
(Masoud et al., 2014; Chevrier et al., 2005). The selected dose
of 500 mg/kg was given orally as it is reported as a safe dose
(Devi et al., 2012).
2.2. DM Induction
DM rats were given a single dose (150 mg/kg interaperi-
toneally) of freshly prepared alloxan monohydrate (Sigma-
Aldrich, USA) dissolved in normal saline (0.9% w/v NaCl)
to induce DM. The levels of blood glucose were estimated in
blood sample collected by tail tipping method using Accu-
Chek Glucometer (China). Animals of glucose levels greater
than 250 g/dl were selected for the study.
2.3. Animals and treatments
Female Albino rats were obtained and housed in the animal
house unit, Sana’a University, Yemen. They were divided ran-Please cite this article in press as: Masoud, A. et al., Antioxidant eﬀect of frankincen
Universities for Basic and Applied Sciences (2016), http://dx.doi.org/10.1016/j.jaubadomly into four groups having 6–8 animals. The study was
conducted for 5 weeks and followed the guidance of animal
care and use, Sana’a University. The doses were given as
follows:
Control Group: These animals were given DMSO solution
(n= 6).
DM group: These animals injected with a single dose of 150/
kg interaperitoneally of alloxan to induce diabetes (n= 8).
FRN group: Animals of this group received ethanolic
extract of FRN (500 mg/kg) dissolved in DMSO solution for
5 weeks (n= 6).
DM+ FRN group: Following DM induction by a single
dose of 150/kg interaperitoneally of alloxan, the animals were
dosed ethanolic extract of FRN (500 mg/kg) dissolved in
DMSO solution for 5 weeks (n= 8).
2.4. Sample preparation and isolation
At the end of the study (5 weeks of FRN administration) ani-
mals were sacrificed by cervical dislocation, their brains were
removed and the cortices were dissected and homogenized in
phosphate buffered saline (pH 7.4). Part of the homogenates
were centrifuged (3000g for 10 min) and the supernatants
and rest of the homogenates were used for biochemical assays,




The total thiol (T-SH) was spectrophotometrically quantified
in the cerebral cortex homogenate according to the method
of Ellman (1959) and as modified by Sedlak and Lindsay
(1968). Tris–HCl (0.2 M) and EDTA (0.02 M, pH 8.2), homo-
genate and 0.01 M DTNB (in methanol) were incubated for
15 min at room temperature then followed by centrifugation
at 1200g for 5 min. The absorbance was read at 412 nm and
the results were expressed as nmoles of T-SH/mg protein using
molar extension coefficient of DTNB (13,600 cm1 M1).
2.5.2. Glutathione contents
Glutathione (GSH) contents were measured in the cerebral
cortex homogenate according to the method of Ellman
(1959). Sulphosalicylic acid (4% w/v) was used to precipitate
proteins, followed by centrifugation at 1200g for 5 min.
0.1 mM DTNB in 0.1 M phosphate buffer (pH 8.0) was added
to the supernatant and the absorbance was read at 412 nm
after 2 min. Results were expressed as nmoles of GSH/mg pro-
tein using molar extension coefficient of DTNB
(13,600 cm1 M1).
2.5.3. Protein thiols
Protein thiols (P-SH) were measured by subtracting the GSH
from T-SH and the results were expressed as nmoles of
P-SH/mg protein using molar extension coefficient of DTNB
(13,600 cm1 M1).
2.5.4. Catalase (CAT) activity
The activity of CAT was measured in the supernatant as
described by Luck (1971). The absorbance of a reactionse extract in the brain cortex of diabetic rats. Journal of the Association of Arab
s.2016.10.003
Table 1 Thiol contents in the brain cortex of control, FRN,
DM, DM+ FRN rats (nmoles/mg protein).
Group/Test GSH P-SH T-SH
Control 5.77 ± 0.80a 21.65 ± 2.34a 27.43 ± 3.14a
FRN 5.41 ± 0.06a 23.40 ± 2.98a 28.82 ± 3.05a
DM 1.92 ± 0.16b 16.14 ± 1.87b 18.06 ± 2.04b
DM+ FRN 4.37 ± 0.16c 19.86 ± 1.38c 24.24 ± 1.54c
Results are expressed as mean ± S.D.; n= 6 in each group.
Superscript alphabets (a, b and c) are significantly different from
their corresponding group, p< 0.05.
Frankincense and diabetic brain 3mixture (supernatant and 12.5 mM H2O2 in 0.067 M phos-
phate buffer (pH 7.0) was followed at 240 nm for 3 min.
Results were expressed as lmoles of H2O2 decomposed/min/
mg protein using molar extinction coefficient of H2O2
(71 M1 cm1).
2.5.5. Protein, albumin and uric acid assays
The biochemical tests include assays of total protein, albumin,
and uric acid (UA) were estimated following the instructions of
commercial kits provided by Spinreact, Spain.
2.5.6. Histopathological studies
Histopathological studies were carried out by performing rou-
tine hematoxylin and eosin staining to evaluate the morpho-
logical and structural changes in the brain cortices and the
slides were examined under light microscope.
2.5.7. Statistical analysis
Data were expressed as mean ± S.D. and were analyzed by
one way ANOVA followed by Student–Newman–Keuls post
hoc test. Differences between groups were considered signifi-
cant when P< 0.05 and all analyses were performed using
the sigma-stat software (version 3.5).
3. Results
Following DM development in rats, administration of FRN
extract showed improvement in the antioxidants parameters
assessed in the present study. The typical signs of DM were
seen (e.g. increase in blood sugar, excessive urine etc.). The
antioxidants of DM group showed sharp reduction in CAT
activity by 4.8-fold as compared to control (Fig. 1), 3-fold
decreases in GSH content, 1.5-fold reduction and T-SH and
1.34-fold decreases in P-SH levels (Table 1). Treatment with
FRN increases significantly the activity of CAT in the brain
cortex of DM+ FRN animals as compared to DM group
(p< 0.05, Fig. 1). This improvement accompanied by increase
in the levels of thiol contents, where T-SH, GSH and P-SH
contents increased in the DM+ FRN group as compared to
DM group (p< 0.05, Table 1). In the all above antioxidants
no significant changes were seen among control and FRNFigure 1 CAT activity in the brain cortices of control, FRN,
DM DM+ FRN groups. Results expressed as mean ± S.D.,
p< 0.05 considered significant compared to control, n= 6 in
each group.
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+ FRN group as compared to both control and FRN groups.
As a result of oxidative damage, proteins and albumin
levels were affected in the brain cortices of DM group
(decreased by 3.68 and 5.05 folds respectively, p< 0.05) when
compared to control (Figs. 2 and 3 respectively). However,
administration of FRN extract brought back the levels of pro-
tein and albumin to almost the similar values of control.
Our results showed 3.23-fold increase in UA in DM group
compared to control, meanwhile, administration of FRN to
DM rats reduces this increase to levels similar to those seen
in control (p< 0.05, Fig. 4).
To evaluate the morphological change in the brain cortices
and comparing them with the biochemical findings, the
histopathological observations showed irregular and large
spaces around neuron cell body in the DM group with cell con-
gestion, however, these changes were slight spaces around neu-
ron cell body in DM+ FRN group (Fig. 5). No
histopathological changes were seen in both control and
FRN groups.
4. Discussion
The increasing evidences of oxidative stress which plays a
major role in the pathogenesis of DM, had lead researchers
looking for natural antioxidants that might play a role in
reducing the damaged caused by DM. Here, we report the pos-
sible involvement of one of those natural antioxidants, FRNFigure 2 Protein levels in the brain cortices of control, FRN,
DM and DM+ FRN groups. Results expressed as mean ± S.D.,
p< 0.05 considered significant compared to control, n= 6 in
each group.
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Figure 3 Albumin levels in the brain cortices of control, FRN,
DM and DM+ FRN groups. Results expressed as mean ± S.D.,
p< 0.05 considered significant compared to control, n= 6 in
each group.
Figure 4 UA levels in the brain cortices of control, FRN, DM
and DM+ FRN groups. Results expressed as mean ± S.D.,
p< 0.05 considered significant compared to control, n= 6 in
each group.
Figure 5 Histopathological changes in the brain cortices of (A)
control (normal observation), (B) FRN (normal observation), (C)
DM (WS, wide space around the neuronal cell bodies) and (D)DM
+ FRN groups (SS, slight space around the neuronal cell bodies).
4 A. Masoud et al.an aromatic resin from Boswellia species that used as anti-
inflammatory, antibacterial, antifungal and anticancer
(Banno et al., 2006; Chevrier et al., 2005; Weckesser et al.,
2007) and as antidiabetic induced by alloxan (Kavitha
et al., 2007; Masoud et al., 2014) or streptozotocin (Azemi
et al., 2012; Shehata et al., 2011). Our results showed that
administration of FRN (500 mg/kg for five weeks) to the
DM rats increases the antioxidant capacities in their brain
cortices, hence, reduces the oxidative stress caused by DM.
It is well established that oxidative stress due to the gener-
ation of free radicals, glucose auto-oxidation and protein gly-
cation plays a role in the development of DM, where, over-
production of free radical disturbs the natural balance between
the production of free radicals and their antioxidant defense
system (Maiese, 2015; Bonnefont-Rousselot, 2004; Desco
et al., 2002; Lenzen, 2008; Muriach et al., 2014; Nowotny
et al., 2015; Yan, 2014; Yang et al., 2011). This was evident
from the data obtained here, where, CAT activity and thiol
contents were reduced significantly in the brain cortex of
DM rats. Concomitantly, there were decreases in the levels
of protein and albumin accompanied by increase in UA indi-
cating disturbance in the antioxidant defense system in the
brain cortices of DM rats. The histopathological changes
includes irregular and wide spaces around neuronal cell bodyPlease cite this article in press as: Masoud, A. et al., Antioxidant eﬀect of frankincense extract in the brain cortex of diabetic rats. Journal of the Association of Arab
Universities for Basic and Applied Sciences (2016), http://dx.doi.org/10.1016/j.jaubas.2016.10.003
Frankincense and diabetic brain 5along with congestion seen in the brain cortex of DM rats sup-
port the biochemical findings. However, FRN showed a relief
in the antioxidants following 500 mg/kg body weight adminis-
tration for 5 weeks. We have seen that CAT activity, thiol con-
tents, protein level, albumin level and UA level came back to
almost the similar levels as seen in the control animals, suggest-
ing the potential antioxidant effect of this natural product. We
reported previously that same dose of FRN helped rat’s red
blood cells (RBCs) to recover from oxidative stress (induced
by alloxan) by increasing the levels of antioxidant (Masoud
et al., 2014). Moreover, FRN showed that it possesses antiox-
idant effect (Azemi et al., 2012; Mothana, 2011; Mothana
et al., 2007, 2009).
One of the metabolic abnormalities of DM is overproduc-
tion of superoxide radical, which is converted to H2O2 by
the action of superoxide dismutase enzyme (Giacco and
Brownlee, 2010). The final product, H2O2, is then processed
by CAT, it is also well documented that the production of xan-
thine oxidase (XO) is increased, which is an enzyme plays
important role in the production of ROS in DM (Romagnoli
et al., 2010; Desco et al., 2002; Matsumoto et al., 2003). Here,
CAT activity was reduced in DM rats and the recovery follow-
ing administration of FRN could be attributed to the antioxi-
dant action of FRN which also helped in the recovery of other
non-enzymatic antioxidants. Due to the presence of sulfhydryl
groups (-SH) in thiols including GSH, they are one of the cel-
lular non-enzymatic antioxidants acting as redox buffer
(Meister and Anderson, 1983) and quenching ROS and other
oxygen-centered free radicals (Kidd, 1997). This could explain
the reductions in thiols in our study, where, oxidative stress
caused by DM overwhelms the presence of natural antioxi-
dants in brain cortices; on the other hand, FRN helped cells
to recover its thiol contents. Elevated UA levels might reflect
the increasing activity of XO, FRN administration in DM
+ FRN group back up the UA level to the similar levels found
in control animals. The administration of FRN results in the
recovery of the antioxidant of brain cortices might be due to
the inhibition of the activity of XO which is responsible for
the production of ROS as other drugs reported to inhibit
XO (Romagnoli et al., 2010). We have reported that the
changes in CAT, thiols and UA have been recovered in the
RBCs of rats exposed to alloxan and treated with FRN extract
(Masoud et al., 2014). In addition to these changes, brain cor-
tices of DM rats showed histopathological changes, where,
irregular and large spaces around neuron cell body along with
cell congestion have been observed in DM group. These obser-
vations were slight spaces around neuron cell body in DM
+ FRN group. Our findings are consistent with different stud-
ies reported histopathological changes following DM induc-
tion (Malone et al., 2006; Edwards et al., 2010; Francis
et al., 2008), however, these findings in contrast to those
reported by Guven et al., who did not observe any changes
in neuron following 4 weeks of STZ-induced diabetes in rats
(Guven et al., 2009).5. Conclusion
In Conclusion, our findings in favor of using FRN to reduce
the oxidative damage caused by DM. Administration of
FRN extract to DM rats showed significant increase in the
antioxidant contents which was confirmed by histopathologi-Please cite this article in press as: Masoud, A. et al., Antioxidant eﬀect of frankincens
Universities for Basic and Applied Sciences (2016), http://dx.doi.org/10.1016/j.jaubacal studies suggesting the antioxidant beneficiary of FRN as
a good candidate in the treatment of conditions that causes
oxidative stress include DM with a suggestion for future study
to reduce the dose less than 500 mg/kg for long period.
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